Key Points
- Oscar Health insider Janet Liang sold 10,360 shares for approximately $325,822 at an average price of $31.45. The Rule 10b5-1 transaction covered tax withholding related to vested equity awards and reduced her ownership by 4%.
- Oscar Health reported quarterly EPS of $1.10, exceeding the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion. Analysts expect full-year EPS of approximately $1.54.
- Institutional investors own 75.7% of the company, and recent analyst actions were mixed; Barclays raised its target to $39, while the consensus rating remains “Hold” with a $26.22 price target.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CAO Victoria Baltrus sold 958 shares of Oscar Health stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the sale, the chief accounting officer owned 213,631 shares in the company, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Oscar Health Stock Up 2.0%
OSCR opened at $32.90 on Wednesday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.55. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a 50-day moving average price of $30.58 and a 200 day moving average price of $23.01. The company has a market cap of $10.15 billion, a PE ratio of 23.50, a price-to-earnings-growth ratio of 0.66 and a beta of 2.37.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. During the same period last year, the company posted ($0.89) EPS. Oscar Health's quarterly revenue was up 70.4% compared to the same quarter last year. Sell-side analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Oscar Health
Several institutional investors and hedge funds have recently bought and sold shares of OSCR. IFP Advisors Inc grew its stake in shares of Oscar Health by 69.5% in the 2nd quarter. IFP Advisors Inc now owns 2,139 shares of the company's stock valued at $61,000 after buying an additional 877 shares during the period. Mraz Amerine & Associates Inc. purchased a new position in Oscar Health in the second quarter worth approximately $284,000. Allworth Financial LP grew its position in Oscar Health by 124.9% in the second quarter. Allworth Financial LP now owns 2,031 shares of the company's stock worth $58,000 after acquiring an additional 1,128 shares during the period. Arizona State Retirement System increased its stake in Oscar Health by 18.1% during the second quarter. Arizona State Retirement System now owns 65,103 shares of the company's stock worth $1,857,000 after acquiring an additional 9,965 shares during the last quarter. Finally, Nykredit A S purchased a new stake in Oscar Health in the second quarter valued at $130,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
OSCR has been the subject of several research reports. UBS Group boosted their price target on Oscar Health from $20.00 to $26.00 and gave the stock a "neutral" rating in a research report on Friday, August 7th. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research note on Friday, August 7th. Zacks Research raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Monday, July 6th. Wells Fargo & Company raised their price target on shares of Oscar Health from $20.00 to $27.00 and gave the stock an "equal weight" rating in a research note on Thursday, August 13th. Finally, Wall Street Zen upgraded shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a research report on Sunday, June 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $26.22.
Check Out Our Latest Stock Report on Oscar Health
Key Headlines Impacting Oscar Health
Here are the key news stories impacting Oscar Health this week:
- Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
- Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
- Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing
About Oscar Health
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
